Salivary analysis of oral cancer biomarkers

por Shpitzer, T, Hamzany, Y, Bahar, G, Feinmesser, R, Savulescu, D, Borovoi, I, Gavish, M, Nagler, R M
Publicado 2009

Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity

por Stish, B J, Oh, S, Chen, H, Dudek, A Z, Kratzke, R A, Vallera, D A
Publicado 2009

Atacicept in relapsed/refractory multiple myeloma or active Waldenström's macroglobulinemia: a phase I study

por Rossi, J-F, Moreaux, J, Hose, D, Requirand, G, Rose, M, Rouillé, V, Nestorov, I, Mordenti, G, Goldschmidt, H, Ythier, A, Klein, B
Publicado 2009

BRCA1 tumours correlate with a HIF-1α phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression

por Yan, M, Rayoo, M, Takano, E A, Thorne, H, Fox, S B
Publicado 2009

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

por Wasan, H S, Springett, G M, Chodkiewicz, C, Wong, R, Maurel, J, Barone, C, Rosbrook, B, Ricart, A D, Kim, S, Spano, J-P
Publicado 2009

Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker

por Munster, P N, Marchion, D, Thomas, S, Egorin, M, Minton, S, Springett, G, Lee, J-H, Simon, G, Chiappori, A, Sullivan, D, Daud, A
Publicado 2009

Direct cancer–stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells

por Semba, S, Kodama, Y, Ohnuma, K, Mizuuchi, E, Masuda, R, Yashiro, M, Hirakawa, K, Yokozaki, H
Publicado 2009

Weekly administration of sagopilone (ZK-EPO), a fully synthetic epothilone, in patients with refractory solid tumours: results of a phase I trial

por Arnold, D, Voigt, W, Kiewe, P, Behrmann, C, Lindemann, S, Reif, S, Wiesinger, H, Giurescu, M, Thiel, E, Schmoll, H-J
Publicado 2009

Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells

por Roberts, D L, Williams, K J, Cowen, R L, Barathova, M, Eustace, A J, Brittain-Dissont, S, Tilby, M J, Pearson, D G, Ottley, C J, Stratford, I J, Dive, C
Publicado 2009

Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas

por Murase, M, Kano, M, Tsukahara, T, Takahashi, A, Torigoe, T, Kawaguchi, S, Kimura, S, Wada, T, Uchihashi, Y, Kondo, T, Yamashita, T, Sato, N
Publicado 2009

Down-regulation of frizzled-7 expression decreases survival, invasion and metastatic capabilities of colon cancer cells

por Ueno, K, Hazama, S, Mitomori, S, Nishioka, M, Suehiro, Y, Hirata, H, Oka, M, Imai, K, Dahiya, R, Hinoda, Y
Publicado 2009

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis

por Fluge, Ø, Gravdal, K, Carlsen, E, Vonen, B, Kjellevold, K, Refsum, S, Lilleng, R, Eide, T J, Halvorsen, T B, Tveit, K M, Otte, A P, Akslen, L A, Dahl, O
Publicado 2009

Cytokeratins 18 and 8 are poor prognostic markers in patients with squamous cell carcinoma of the oesophagus

por Makino, T, Yamasaki, M, Takeno, A, Shirakawa, M, Miyata, H, Takiguchi, S, Nakajima, K, Fujiwara, Y, Nishida, T, Matsuura, N, Mori, M, Doki, Y
Publicado 2009

Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors

por Flågeng, M Hauglid, Haugan Moi, L L, Dixon, J M, Geisler, J, Lien, E A, Miller, W R, Lønning, P E, Mellgren, G
Publicado 2009

Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis

por Fernández-Ramires, R, Solé, X, De Cecco, L, Llort, G, Cazorla, A, Bonifaci, N, Garcia, M J, Caldés, T, Blanco, I, Gariboldi, M, Pierotti, M A, Pujana, M A, Benítez, J, Osorio, A
Publicado 2009

Absence of VHL gene alteration and high VEGF expression are associated with tumour aggressiveness and poor survival of renal-cell carcinoma

por Patard, J-J, Rioux-Leclercq, N, Masson, D, Zerrouki, S, Jouan, F, Collet, N, Dubourg, C, Lobel, B, Denis, M, Fergelot, P
Publicado 2009

CD8+ lymphocytes/ tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’ approach to tumour host interaction in colorectal cancer

por Lugli, A, Karamitopoulou, E, Panayiotides, I, Karakitsos, P, Rallis, G, Peros, G, Iezzi, G, Spagnoli, G, Bihl, M, Terracciano, L, Zlobec, I
Publicado 2009

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

por Kishida, Y, Kawahara, M, Teramukai, S, Kubota, K, Komuta, K, Minato, K, Mio, T, Fujita, Y, Yonei, T, Nakano, K, Tsuboi, M, Shibata, K, Atagi, S, Kawaguchi, T, Furuse, K, Fukushima, M
Publicado 2009

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment

por Byrne, A T, O'Connor, A E, Hall, M, Murtagh, J, O'Neill, K, Curran, K M, Mongrain, K, Rousseau, J A, Lecomte, R, McGee, S, Callanan, J J, O'Shea, D F, Gallagher, W M
Publicado 2009

Curcumin induces apoptosis-independent death in oesophageal cancer cells

por O'Sullivan-Coyne, G, O'Sullivan, G C, O'Donovan, T R, Piwocka, K, McKenna, S L
Publicado 2009